Eswatini vs Gabon: The number of people with susceptibility test result for rifampicin
Eswatini
953
in 2021
Gabon
807
in 2021
Eswatini rank
68th
Gabon rank
70th
The number of people with susceptibility test result for rifampicin over time
- Eswatini
- Gabon
How they compare
Eswatini currently reports 953 against 807 in Gabon, a difference of 146.
That makes Eswatini's figure about 1.2 times Gabon's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Eswatini ahead.
Eswatini ranks 68th and Gabon ranks 70th of 155 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,737 | 1,104 | 633.33 | Eswatini |
| 2020s | 1,028 | 722 | 306.5 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Eswatini or Gabon?
- Eswatini, at 953 against 807 in Gabon as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Eswatini and Gabon?
- 146, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Gabon?
- 5 years are reported by both, from 2017 to 2021.
- How do Eswatini and Gabon rank globally for the number of people with susceptibility test result for rifampicin?
- Eswatini ranks 68th and Gabon ranks 70th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.